Vaginal Bleeding Associated with Venlafaxine Add-On Therapy: A Case Report / 대한정신약물학회지
Korean Journal of Psychopharmacology
; : 238-240, 2006.
Article
Dans Ko
| WPRIM
| ID: wpr-24409
Responsable en Bibliothèque :
WPRO
ABSTRACT
Venlafaxine is often considered to be safer than established antidepressants except the risk of hypertension. In terms of vaginal bleeding associated with venlafaxine, only one case has been reported. The author describes a vaginal bleeding occurred in a 38-year-old depressed patient who has been receiving additional venlafaxine during fluoxetine medication. Discontinuation of venlafaxine supported the assumption that the vaginal bleeding was an adverse drug reaction of venlafaxine. Physicians should be alerted to the possibility of bleeding tendency in patients who have taken venlafaxine.
Texte intégral:
1
Indice:
WPRIM
Sujet Principal:
Hémorragie utérine
/
Fluoxétine
/
Effets secondaires indésirables des médicaments
/
Chlorhydrate de venlafaxine
/
Hémorragie
/
Hypertension artérielle
/
Antidépresseurs
Limites du sujet:
Adult
/
Humans
langue:
Ko
Texte intégral:
Korean Journal of Psychopharmacology
Année:
2006
Type:
Article